Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Patel, Shyam

One or more keywords matched the following properties of Patel, Shyam

Property	Value
keywords	Myelodysplastic Syndrome
overview	Dr. Patel attended Rutgers – New Jersey Medical School and Rutgers - Graduate School of Biomedical Sciences from 2006-13, where he completed the physician-scientist training program (PSTP). He trained in the disciplines of stem cell biology and cancer biology. His prior research focused on breast cancer dormancy in the bone marrow. He then completed Internal Medicine residency at Stanford University (2013-16) and Hematology/Oncology fellowship at Stanford University (2016-19), during which time he studied the leukemic stem cell niche in acute myeloid leukemia (AML). He is board-certified in Internal Medicine (2016), Hematology (2019), and Medical Oncology (2019). His current research involves understanding the disease biology and clonal dynamics of TP53-mutant MDS and AML, as well as the genomics of clonal hematopoiesis (Patel SA et al., Br J Haematol 2024). The Darkest Side of AML: The TP53 Mutation (umassmed.edu) Dr. Patel is part of the hematologic malignancies and stem cell transplant team that treats acute leukemia, myeloid malignancies, myelodysplastic syndrome, myeloproliferative neoplasms, lymphoma, and multiple myeloma.

Property

Value

keywords

Myelodysplastic Syndrome

overview

Dr. Patel attended Rutgers – New Jersey Medical School and Rutgers - Graduate School of Biomedical Sciences from 2006-13, where he completed the physician-scientist training program (PSTP). He trained in the disciplines of stem cell biology and cancer biology. His prior research focused on breast cancer dormancy in the bone marrow. He then completed Internal Medicine residency at Stanford University (2013-16) and Hematology/Oncology fellowship at Stanford University (2016-19), during which time he studied the leukemic stem cell niche in acute myeloid leukemia (AML). He is board-certified in Internal Medicine (2016), Hematology (2019), and Medical Oncology (2019).

His current research involves understanding the disease biology and clonal dynamics of TP53-mutant MDS and AML, as well as the genomics of clonal hematopoiesis (Patel SA et al., Br J Haematol 2024).

The Darkest Side of AML: The TP53 Mutation (umassmed.edu)

Dr. Patel is part of the hematologic malignancies and stem cell transplant team that treats acute leukemia, myeloid malignancies, myelodysplastic syndrome, myeloproliferative neoplasms, lymphoma, and multiple myeloma.

One or more keywords matched the following items that are connected to Patel, Shyam

Item Type	Name
Concept	Syndrome
Concept	Myelodysplastic Syndromes
Concept	Budd-Chiari Syndrome
Academic Article	Myelodysplastic Syndrome and Acute Myeloid Leukemia Risk Associated With Solid Tumor Chemotherapy.
Academic Article	Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia.
Academic Article	The inferior vena cava (IVC) syndrome as the initial manifestation of newly diagnosed gastric adenocarcinoma: a case report.
Academic Article	Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience.
Academic Article	Clinico-genomic profiling and clonal dynamic modeling of TP53-aberrant myelodysplastic syndrome and acute myeloid leukemia.
Academic Article	TP53-mutant myelodysplastic syndrome and acute myeloid leukemia: the black hole of hematology.
Academic Article	Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions.

Search Criteria

Syndrome